NeueHealth Inc

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

NeueHealth excels in Q1 2024, poised for growth and profitability

NeueHealth's Q1 performance reflects strong financial results and operational achievements across its segments.
The company's solid cash position and credit facility enhancement provide a strong foundation for future growth.
While facing challenges in the ACA business wind-down and industry dynamics, NeueHealth is well-positioned to capitalize on growth opportunities.
Strategic focus on operational efficiency and revenue targets will be key for NeueHealth's success in 2024.

NeueHealth secures funding, reports strong Q2 performance and outlook

NeueHealth demonstrated strong financial performance and strategic initiatives in Q2 2024, positioning the company for growth and success in the healthcare sector.
While facing challenges in winding down its ACA insurance business, NeueHealth's focus on consumer-centric care and financial stability provides a solid foundation for future endeavors.
With a positive outlook for 2024 and a robust cash position, NeueHealth is well-equipped to navigate challenges and capitalize on opportunities in the evolving healthcare landscape.

NeueHealth excels in Q3, eyes growth through diversification and acquisitions

NeueHealth's Q3 2024 performance reflects financial strength and operational efficiency, meeting full-year guidance and showcasing growth potential.
While facing challenges in certain segments, strategic acquisitions and a focus on consumer-centric care position NeueHealth for future success.
The company's strong cash position and strategic growth areas provide a solid foundation for continued expansion and innovation in the healthcare market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. It offers individual and family, and Medicare Advantage health plans. It operates through the Bright HealthCare and NeueHealth segments. The Bright HealthCare segment offers commercial and Medicare health plan products. The NeueHealth segment provides care delivery and value-based enablement services. The company was founded by Robert J. Sheehy, Tomas Valdivia, and Kyle Rolfing in 2015 and is headquartered in Doral, FL.

LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.

NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / December 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into NeueHealth, Inc. For Securities Fraud

NEW YORK CITY, NY / ACCESSWIRE / December 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.

NEUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into NeueHealth, Inc. and Encourages Investors to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--NEUE Investors Have the Opportunity to Join Investigation of NeueHealth, Inc. with the Schall Law Firm.

NEUE Investors Have the Opportunity to Join Investigation of NeueHealth, Inc. with the Schall Law Firm

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of NeueHealth, Inc. (NYSE: NEUE) to an affiliate of New Enterprise Associates for $7.33 per share in cash is fair to NeueHealth shareholders. Halper Sadeh encourages NeueHealth shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation conce.

NEUE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NeueHealth, Inc. Is Fair to Shareholders

Health insurer NeueHealth said on Monday that an affiliate of New Enterprise Associates and a consortium of investors would take it private at an enterprise value of about $1.3 billion.

NeueHealth to be taken private by New Enterprise Associates in $1.3 billion deal

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates (“NEA”) at an enterprise value of approximately $1.3 billion. Upon completion of the transaction, NeueHealth will become a privately held company with the flexibility and resources to continue advancing its.

NeueHealth to Be Taken Private by NEA and Consortium of Investors

NeueHealth, Inc. (NYSE:NEUE ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President and CEO Jay Matushak - CFO Conference Call Participants Operator Ladies and gentlemen, welcome to the NeueHealth Third Quarter 2024 Earnings Call. My name is Kenneth, and I will be coordinating your call today.

NeueHealth, Inc. (NEUE) Q3 2024 Earnings Conference Call Transcript

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its third quarter ended September 30, 2024. “We are pleased to report another quarter of strong financial performance as we continue to build on the positive momentum we have generated so far this year,” said Mike Mikan, President and CEO of NeueHealth. “We have delivered Adjusted EBITDA profitability for three consecutive quarter.

Neuehealth Reports Third Quarter 2024 Results

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that Centrum Health, one of the Company's value-driven clinic brands, became a wholly owned subsidiary through the Company's acquisition of the remaining 25% equity interest of the business that it did not already own. This action simplifies NeueHealth's corporate structure, streamlining operations to support its ongoing focus on advancing its value-d.

NeueHealth Acquires Full Ownership of Centrum Health

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Thursday, November 7, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in nu.

NeueHealth to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024

NeueHealth (NEUE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

NeueHealth (NEUE) Upgraded to Buy: What Does It Mean for the Stock?

NeueHealth, Inc. (NYSE:NEUE ) Q2 2024 Earnings Conference Call August 7, 2024 8:00 AM ET Company Participants Emily Lombardi - Investor Relations Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Conference Call Participants Operator Good morning, all. Welcome to the NeueHealth Q2 2024 Earnings Call.

NeueHealth, Inc. (NEUE) Q2 2024 Earnings Call Transcript

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2024. “We continued to build momentum in the second quarter, driving solid results in both our NeueCare and NeueSolutions segments as we deliver a seamless, more coordinated care experience to all populations,” said Mike Mikan, President and CEO of NeueHealth. “We have built strong, ongoing relati.

NeueHealth Reports Second Quarter 2024 Results

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 7, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in nu.

NeueHealth to Host Second Quarter 2024 Earnings Conference Call on August 7, 2024

Hercules Capital

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it entered into a secured loan facility for up to $150 million with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). “This financing puts us in a strong position to advance our differentiated care model and take the lead as the industry continues to shift to value-based care,” said Mike Mikan, President and CEO of NeueHealth. “We have establishe.

NeueHealth Secures up to $150 Million in New Term Loan Facility with Hercules Capital

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that on June 12, 2024, the Company received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company no longer satisfies the continued listing standards set forth under Section 802.01B of the NYSE's Listed Company Manual. The notice cited that the Company's average market capitalization over a consecutive 30 tradi.

NeueHealth Receives NYSE Non-Compliance Letter Regarding Market Capitalization Requirements

NeueHealth, Inc. (NYSE:NEUE ) Q1 2024 Earnings Conference Call May 8, 2024 8:00 AM ET Company Participants Emily Lombardi - Investor Relations Mike Mikan - President and Chief Executive Officer Jay Matushak - Chief Financial Officer Conference Call Participants Marco Criscuolo - Nephron Research LLC Operator Good morning, everyone, and welcome to the NeueHealth Q1 2024 Earnings Call. My name is Drew, and I'll be the operator for today.

NeueHealth, Inc. (NEUE) Q1 2024 Earnings Call Transcript

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its First Quarter ended March 31, 2024. “We had a strong start to the year, continuing to advance our value-driven, consumer-centric care model as we build on our strong relationships with providers and payors to make high-quality healthcare more accessible and affordable for all populations across the ACA Marketplace, Medicare, a.

NeueHealth Reports First Quarter 2024 Results

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report First Quarter financial results before the financial markets open on Wednesday, May 8, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number.

NeueHealth to Host First Quarter 2024 Earnings Conference Call on May 8, 2024

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it entered into an incremental amendment to its credit facility with New Enterprise Associates (“NEA”) that increases the term loan commitment by $30 million on April 8, 2024. The proceeds of the incremental commitment are intended to be used for general corporate purposes, including to support the Company's 2024 strategic priorities. In connecti.

NeueHealth Enters into Amendment to its Credit Facility

NeueHealth, Inc. Q4 2023 Earnings Conference Call March 6, 2024 12:00 AM ET Company Participants Emily Lombardi - Investor Relations Mike Mikan - President and CEO Jay Matushak - CFO Tomas Orozco - Executive Vice President Conference Call Participants Joshua Raskin - Nephron Research Operator Good morning. My name is Drew, and I'll be your conference operator today.

NeueHealth, Inc. (NEUE) Q4 2023 Earnings Call Transcript

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2023. “We achieved significant milestones as a company this past year, completing the sale of our California Medicare Advantage business and fully focusing on where we have proven to have the greatest impact - through our care delivery and provider enablement business,” said Mike.

NeueHealth Reports Fourth Quarter and Full Year 2023 Results

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth (NYSE: NEUE) will report Fourth Quarter financial results Wednesday, March 6, 2024.

News for NeueHealth Inc Stock (NEUE)